FDA Approves NDA Supported By MedAvante Central Ratings – Daily Markets

The Company’s first product is a fenofibrate formulation marketed in the United States as Lipofen®. Cipher’s second product, an extended-release tramadol, is marketed in the United States as ConZip™ and is marketed in Canada as Durela™. 

Posted in Uncategorized